Ru Yue Shen, Yuqiao Zhang, Li Jia Chen, Carol Y Cheung, Yuanbo Liang, Clement C Tham, Poemen P Chan
{"title":"原发性青光眼的眼部和全身危险因素和生物标志物:综合系统评价和荟萃分析。","authors":"Ru Yue Shen, Yuqiao Zhang, Li Jia Chen, Carol Y Cheung, Yuanbo Liang, Clement C Tham, Poemen P Chan","doi":"10.1167/iovs.66.12.35","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To synthesize and evaluate the quality of evidence from existing meta-analyses on ocular and systemic factors and biomarkers associated with primary glaucoma.</p><p><strong>Methods: </strong>Systematic reviews with meta-analysis evaluating ocular and systemic factors or biomarkers of glaucoma were included. Searches of PubMed, Embase, and Cochrane Library were conducted from inception to June 25, 2023, without language restrictions. Two researchers independently conducted screening, data extraction, and quality appraisal. The summary effect size, 95% confidence interval, and 95% prediction interval were estimated by random-effect models. The between-study heterogeneity (I2), evidence of small-study effects, and evidence of excess significance bias were reported. The equivalent standardized mean differences or odds ratios were calculated from original study estimates.</p><p><strong>Results: </strong>Thirty-six systematic reviews and meta-analyses were included, examining 87 factors related to ocular biometrics, lifestyle habits, diets, ocular and systemic disorders, and biomarkers from ocular imaging, serum, plasma, and aqueous humor. Three ocular factors (intraocular pressure, myopia, and corneal hysteresis) and one peripheral biomarker (total antioxidant status) were graded as highly suggestive evidence. Among the 41 factors, 8 (20%) were classified as suggestive evidence, while 3 (7%) of the 46 biomarkers received the same classification. Additionally, 29 of 54 (54%) factors and 18 of 33 (55%) biomarkers were graded as weak evidence.</p><p><strong>Conclusions: </strong>This umbrella review highlights the evidence hierarchy of various ocular and systemic risk factors and biomarkers associated with glaucoma. Further high-quality studies are essential to strengthen the evidence base.</p>","PeriodicalId":14620,"journal":{"name":"Investigative ophthalmology & visual science","volume":"66 12","pages":"35"},"PeriodicalIF":4.7000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12448150/pdf/","citationCount":"0","resultStr":"{\"title\":\"Ocular and Systemic Risk Factors and Biomarkers for Primary Glaucoma: An Umbrella Review of Systematic Reviews With Meta-Analyses.\",\"authors\":\"Ru Yue Shen, Yuqiao Zhang, Li Jia Chen, Carol Y Cheung, Yuanbo Liang, Clement C Tham, Poemen P Chan\",\"doi\":\"10.1167/iovs.66.12.35\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To synthesize and evaluate the quality of evidence from existing meta-analyses on ocular and systemic factors and biomarkers associated with primary glaucoma.</p><p><strong>Methods: </strong>Systematic reviews with meta-analysis evaluating ocular and systemic factors or biomarkers of glaucoma were included. Searches of PubMed, Embase, and Cochrane Library were conducted from inception to June 25, 2023, without language restrictions. Two researchers independently conducted screening, data extraction, and quality appraisal. The summary effect size, 95% confidence interval, and 95% prediction interval were estimated by random-effect models. The between-study heterogeneity (I2), evidence of small-study effects, and evidence of excess significance bias were reported. The equivalent standardized mean differences or odds ratios were calculated from original study estimates.</p><p><strong>Results: </strong>Thirty-six systematic reviews and meta-analyses were included, examining 87 factors related to ocular biometrics, lifestyle habits, diets, ocular and systemic disorders, and biomarkers from ocular imaging, serum, plasma, and aqueous humor. Three ocular factors (intraocular pressure, myopia, and corneal hysteresis) and one peripheral biomarker (total antioxidant status) were graded as highly suggestive evidence. Among the 41 factors, 8 (20%) were classified as suggestive evidence, while 3 (7%) of the 46 biomarkers received the same classification. Additionally, 29 of 54 (54%) factors and 18 of 33 (55%) biomarkers were graded as weak evidence.</p><p><strong>Conclusions: </strong>This umbrella review highlights the evidence hierarchy of various ocular and systemic risk factors and biomarkers associated with glaucoma. Further high-quality studies are essential to strengthen the evidence base.</p>\",\"PeriodicalId\":14620,\"journal\":{\"name\":\"Investigative ophthalmology & visual science\",\"volume\":\"66 12\",\"pages\":\"35\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12448150/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Investigative ophthalmology & visual science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1167/iovs.66.12.35\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Investigative ophthalmology & visual science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1167/iovs.66.12.35","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Ocular and Systemic Risk Factors and Biomarkers for Primary Glaucoma: An Umbrella Review of Systematic Reviews With Meta-Analyses.
Purpose: To synthesize and evaluate the quality of evidence from existing meta-analyses on ocular and systemic factors and biomarkers associated with primary glaucoma.
Methods: Systematic reviews with meta-analysis evaluating ocular and systemic factors or biomarkers of glaucoma were included. Searches of PubMed, Embase, and Cochrane Library were conducted from inception to June 25, 2023, without language restrictions. Two researchers independently conducted screening, data extraction, and quality appraisal. The summary effect size, 95% confidence interval, and 95% prediction interval were estimated by random-effect models. The between-study heterogeneity (I2), evidence of small-study effects, and evidence of excess significance bias were reported. The equivalent standardized mean differences or odds ratios were calculated from original study estimates.
Results: Thirty-six systematic reviews and meta-analyses were included, examining 87 factors related to ocular biometrics, lifestyle habits, diets, ocular and systemic disorders, and biomarkers from ocular imaging, serum, plasma, and aqueous humor. Three ocular factors (intraocular pressure, myopia, and corneal hysteresis) and one peripheral biomarker (total antioxidant status) were graded as highly suggestive evidence. Among the 41 factors, 8 (20%) were classified as suggestive evidence, while 3 (7%) of the 46 biomarkers received the same classification. Additionally, 29 of 54 (54%) factors and 18 of 33 (55%) biomarkers were graded as weak evidence.
Conclusions: This umbrella review highlights the evidence hierarchy of various ocular and systemic risk factors and biomarkers associated with glaucoma. Further high-quality studies are essential to strengthen the evidence base.
期刊介绍:
Investigative Ophthalmology & Visual Science (IOVS), published as ready online, is a peer-reviewed academic journal of the Association for Research in Vision and Ophthalmology (ARVO). IOVS features original research, mostly pertaining to clinical and laboratory ophthalmology and vision research in general.